Breakthrough in COVID-19 fight; Healthcare professionals welcome UK company develops protein-based treatment
By Dr Ahmed Mohiuddin Siddiqui A United Kingdom (UK) based biotech company, Synairgen has declared positive “breakthrough” results from a clinical trial of a protein-based treatment for COVID-19, which ‘greatly’ reduced patients requiring intensive care. Synairgen said its SNG001 formulation uses a protein called interferon beta, which the body produces when it gets a viral infection. It is inhaled directly into the lungs of patients with coronavirus, using a nebuliser, which will stimulate an immune response. According to…





